Unknown

Dataset Information

0

CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice.


ABSTRACT: Rationale:Increased IL-8 levels and neutrophil accumulation in the airways are common features found in patients affected by pulmonary diseases such as Asthma, Idiopathic Pulmonary Fibrosis, Influenza-A infection and COPD. Chronic neutrophilic inflammation is usually corticosteroid insensitive and may be relevant in the progression of those diseases. Objective:To explore the role of Ladarixin, a dual CXCR1/2 antagonist, in several mouse models of airway inflammation with a significant neutrophilic component. Findings:Ladarixin was able to reduce the acute and chronic neutrophilic influx, also attenuating the Th2 eosinophil-dominated airway inflammation, tissue remodeling and airway hyperresponsiveness. Correspondingly, Ladarixin decreased bleomycin-induced neutrophilic inflammation and collagen deposition, as well as attenuated the corticosteroid resistant Th17 neutrophil-dominated airway inflammation and hyperresponsiveness, restoring corticosteroid sensitivity. Finally, Ladarixin reduced neutrophilic airway inflammation during cigarette smoke-induced corticosteroid resistant exacerbation of Influenza-A infection, improving lung function and mice survival. Conclusion:CXCR1/2 antagonist Ladarixin offers a new strategy for therapeutic treatment of acute and chronic neutrophilic airway inflammation, even in the context of corticosteroid-insensitivity.

SUBMITTER: Mattos MS 

PROVIDER: S-EPMC7566412 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Rationale</h4>Increased IL-8 levels and neutrophil accumulation in the airways are common features found in patients affected by pulmonary diseases such as Asthma, Idiopathic Pulmonary Fibrosis, Influenza-A infection and COPD. Chronic neutrophilic inflammation is usually corticosteroid insensitive and may be relevant in the progression of those diseases.<h4>Objective</h4>To explore the role of Ladarixin, a dual CXCR1/2 antagonist, in several mouse models of airway inflammation with a signifi  ...[more]

Similar Datasets

| S-EPMC9540558 | biostudies-literature
| S-EPMC8471705 | biostudies-literature
| S-EPMC3867427 | biostudies-literature
| S-EPMC6822417 | biostudies-literature
| S-EPMC9847559 | biostudies-literature
| S-EPMC9902528 | biostudies-literature
| S-EPMC4833178 | biostudies-literature
| S-EPMC5717344 | biostudies-literature
| S-EPMC5618543 | biostudies-literature
| S-EPMC2696769 | biostudies-literature